What one share of Zai Lab Limited holds
We are a patient-focused, innovative, commercial-stage, global biopharmaceutical company with a substantial presence in both Greater China and the United States. We are focused on discovering, developing, and commercializing products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease.
Zai Lab Limited’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.41 |
|---|---|
| Profit | −$0.17 |
| Capex (buildings and equipment) | $0.01 |
| Free cash flow | −$0.13 |
| Cash and investments | $0.54 |
| Book value | $0.54 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | — | −$0.21 | $0.01 | −$0.14 | — | −$0.21 |
| 2016 | — | −$0.40 | $0.02 | −$0.36 | — | −$0.53 |
| 2017 | — | −$0.23 | $0.04 | −$0.19 | — | — |
| 2018 | — | −$0.26 | $0.02 | −$0.20 | — | $0.43 |
| 2019 | $0.02 | −$0.30 | $0.01 | −$0.31 | — | $0.43 |
| 2020 | $0.06 | −$0.35 | $0.01 | −$0.29 | — | $1.33 |
| 2021 | $0.16 | −$0.76 | $0.02 | −$0.61 | — | $1.45 |
| 2022 | $0.22 | −$0.46 | $0.03 | −$0.41 | — | $1.09 |
| 2023 | $0.28 | −$0.35 | $0.01 | −$0.21 | — | $0.82 |
| 2024 | $0.40 | −$0.26 | $0.01 | −$0.22 | — | $0.78 |
| 2025 | $0.42 | −$0.16 | $0.01 | −$0.15 | — | $0.65 |
Common questions about Zai Lab Limited
How much does one share of Zai Lab Limited earn?
Over the last 12 months, Zai Lab Limited lost $0.17 for each share on $0.41 of sales.
Does Zai Lab Limited pay a dividend?
Zai Lab Limited didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Zai Lab Limited’s book value per share?
Zai Lab Limited’s book value is $0.54 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Zai Lab Limited have?
Each share of Zai Lab Limited has $0.54 of cash and investments, as of June 30, 2026.
What is Zai Lab Limited’s free cash flow per share?
−$0.13 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Zai Lab Limited bought back shares?
Zai Lab Limited’s share count rose about 1160% from 2015 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.